Synvisc-one syringe 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR9AC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,707
Award facts
- Contract value 100% obligated
- $18,707.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,707.28 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price contract, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a major pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. The IDC demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements on a competitive basis, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FR9AC?
SPE2DR26FR9AC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FR9AC worth?
The government has obligated $18,707 on SPE2DR26FR9AC.
Is contract SPE2DR26FR9AC an order under another contract?
Yes. SPE2DR26FR9AC is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR9AC competed?
The extent of competition for SPE2DR26FR9AC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award